As of Aug 26
| -0.0709 / -9.86%|
The 1 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +362.89% increase from the last price of 0.65.
The current consensus among 3 polled investment analysts is to Hold stock in Pernix Therapeutics Holdings Inc. This rating has held steady since August, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.